LEI 984500F1E5BR868E3967
Aurigon Labs Zártkörűen Működő Részvénytársaság
Contract awards & public grants
Next Generation Vaccine Platform Leveraging Skin Immunity to Provide Disease-Modifying Treatment of Parkinson’s Disease → AURIGON LABS ZARTKORUEN MUKODO RESZVENYTARSASAG
European Commission · HU · Grant · 2023-03-15
€551,419
Vaccine for prevention and treatment of Trypanosoma cruzi infection → AURIGON LABS ZARTKORUEN MUKODO RESZVENYTARSASAG
European Commission · HU · Grant · 2019-04-30
€863,593
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.